Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Neurochemistry|February 1, 1995
Release of glutamate from striatum of freely moving rats by pros-methylimidazoleacetic acidP Blandina, G Cherici, F Moroni, et al.
Agents and Actions|March 1, 1989
Rostral-caudal concentration gradients of histamine metabolites in human cerebrospinal fluidG D Prell, J K Khandelwal, P A LeWitt, et al.
British Journal of Pharmacology|April 1, 1995
Interaction of clozapine with the histamine H3 receptor in rat brainA A Rodrigues, F P Jansen, R Leurs, et al.
Agents and Actions|March 1, 1991
Effects of aminoguanidine on pre- and post-irradiation regional cerebral blood flow, systemic blood pressure and plasma histamine levels in the primateL G Cockerham, G D Prell, T J Cerveny, et al.
Archives of Gerontology and Geriatrics|July 1, 1990
Influence of age and gender on the levels of histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluidG D Prell, J K Khandelwal, R S Burns, et al.
Archives of Gerontology and Geriatrics|January 1, 1991
Influence of age and gender on the levels of histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluidG D Prell, J K Khandelwal, R S Burns, et al.
Comprehensive Gerontology. Section A, Clinical and Laboratory Sciences|October 1, 1988
Elevated levels of histamine metabolites in cerebrospinal fluid of aging, healthy humansG D Prell, J K Khandelwal, R S Burns, et al.
British Journal of Pharmacology|August 1, 1996
[3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortexA Alves-Rodrigues, R Leurs, T S Wu, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Levels of pros-methylimidazoleacetic acid: correlation with severity of Parkinson's disease in CSF of patients and with the depletion of striatal dopamine and its metabolites in MPTP-treated miceG D Prell, J K Khandelwal, R S Burns, et al.
Clinical Neuropharmacology|August 1, 1996
An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacyR B Rosse, K Kendrick, M Fay-McCarthy, et al.
Pageof 4